157 related articles for article (PubMed ID: 3700244)
21. A new antitumor substance, BE-18591, produced by a streptomycete. I. Fermentation, isolation, physico-chemical and biological properties.
Kojiri K; Nakajima S; Suzuki H; Okura A; Suda H
J Antibiot (Tokyo); 1993 Dec; 46(12):1799-803. PubMed ID: 8294236
[TBL] [Abstract][Full Text] [Related]
22. The kapurimycins, new antitumor antibiotics produced by Streptomyces. Producing organism, fermentation, isolation and biological activities.
Hara M; Mokudai T; Kobayashi E; Gomi K; Nakano H
J Antibiot (Tokyo); 1990 Dec; 43(12):1513-8. PubMed ID: 2276970
[TBL] [Abstract][Full Text] [Related]
23. Maggiemycin and anhydromaggiemycin: two novel anthracyclinone antitumor antibiotics. Isolation, structures, partial synthesis and biological properties.
Pandey RC; Toussaint MW; McGuire JC; Thomas MC
J Antibiot (Tokyo); 1989 Nov; 42(11):1567-77. PubMed ID: 2584139
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of terpentecin, a new antitumor antibiotic.
Tamamura T; Sawa T; Isshiki K; Masuda T; Homma Y; Inuma H; Naganawa H; Hamada M; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Dec; 38(12):1664-9. PubMed ID: 3841535
[TBL] [Abstract][Full Text] [Related]
25. New aureolic acid antibiotics. I. Screening, isolation, characterization and biological properties.
Koenuma M; Uchida N; Yamaguchi K; Kawamura Y; Matsumoto K
J Antibiot (Tokyo); 1988 Jan; 41(1):45-52. PubMed ID: 3346192
[TBL] [Abstract][Full Text] [Related]
26. DC89-A1, a new antitumor antibiotic from Streptomyces.
Ichimura M; Muroi K; Asano K; Kawamoto I; Tomita F; Morimoto M; Nakano H
J Antibiot (Tokyo); 1988 Sep; 41(9):1285-8. PubMed ID: 3141339
[No Abstract] [Full Text] [Related]
27. New anthracycline glycosides from Micromonospora. II. isolation, characterization and biological properties.
Cassinelli G; Di Matteo F; Forenza S; Ripamonti MC; Rivola G; Arcamone F; Di Marco A; Casazza AM; Soranzo C; Pratesi G
J Antibiot (Tokyo); 1980 Dec; 33(12):1468-73. PubMed ID: 6941955
[TBL] [Abstract][Full Text] [Related]
28. A novel macromolecular antibiotic, SN-07. Taxonomy of producing organism, isolation, characterization and biological activities.
Kikuchi Y; Niwano M; Yajima N; Nakamura G; Miyata N
J Antibiot (Tokyo); 1985 Dec; 38(12):1670-6. PubMed ID: 4093331
[TBL] [Abstract][Full Text] [Related]
29. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity.
Tsunakawa M; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H
J Antibiot (Tokyo); 1988 Oct; 41(10):1366-73. PubMed ID: 3192492
[TBL] [Abstract][Full Text] [Related]
30. New rhodomycin analogs, SS-288A and SS-288B, produced by a Streptomyces violaceus A262 mutant.
Saito S; Katsuda Y; Johdo O; Yoshimoto A
Biosci Biotechnol Biochem; 1995 Jan; 59(1):135-7. PubMed ID: 7765964
[TBL] [Abstract][Full Text] [Related]
31. [Anthracycline antibiotics from genetically modified streptomycetes. The isolation, spectroscopic structural elucidation and biologic effects of beta-rhodomycin I].
Ihn W; Schlegel B; Fleck WF; Tresselt D; Gutsche W; Sedmera P; Vokoun J
Pharmazie; 1984 Mar; 39(3):176-80. PubMed ID: 6427794
[TBL] [Abstract][Full Text] [Related]
32. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
[TBL] [Abstract][Full Text] [Related]
33. Sandramycin, a novel antitumor antibiotic produced by a Nocardioides sp. Production, isolation, characterization and biological properties.
Matson JA; Bush JA
J Antibiot (Tokyo); 1989 Dec; 42(12):1763-7. PubMed ID: 2621159
[TBL] [Abstract][Full Text] [Related]
34. [Cytotoxic compounds from the marine actinobacterium].
Adinarayana G; Venkateshan MR; Bapiraju VV; Sujatha P; Premkumar J; Ellaiah P; Zeeck A
Bioorg Khim; 2006; 32(3):328-34. PubMed ID: 16808176
[TBL] [Abstract][Full Text] [Related]
35. Saquayamycins, new aquayamycin-group antibiotics.
Uchida T; Imoto M; Watanabe Y; Miura K; Dobashi T; Matsuda N; Sawa T; Naganawa H; Hamada M; Takeuchi T
J Antibiot (Tokyo); 1985 Sep; 38(9):1171-81. PubMed ID: 3840796
[TBL] [Abstract][Full Text] [Related]
36. Antitumor agents from bohemic acid complex, VI. Schaunardimycin.
Nettleton DE; Doyle TW; Grossman JH; Bradner WT; Moseley JE; Bray SW
J Nat Prod; 1984; 47(4):698-701. PubMed ID: 6491682
[No Abstract] [Full Text] [Related]
37. [Kafamycin--a new pyrrol ether antibiotic].
Murenets NV; Kudinova MK; Korobkova TP; Drobysheva TN; Kliuev NA
Antibiot Med Biotekhnol; 1987 Nov; 32(11):811-4. PubMed ID: 2830837
[TBL] [Abstract][Full Text] [Related]
38. A new anthracycline antibiotic, IT-62-B, converts the morphology of ras-transformed cells back to normal: taxonomy, fermentation, isolation, structure elucidation and biological characterization.
Kawauchi T; Sasaki T; Yoshida K; Matsumoto H; Chen RX; Huang MY; Tsuchiya KS; Otani T
J Antibiot (Tokyo); 1997 Apr; 50(4):297-303. PubMed ID: 9186553
[TBL] [Abstract][Full Text] [Related]
39. Prothracarcin, a novel antitumor antibiotic.
Shimizu K; Kawamoto I; Tomita F; Morimoto M; Fujimoto K
J Antibiot (Tokyo); 1982 Aug; 35(8):972-8. PubMed ID: 7142014
[TBL] [Abstract][Full Text] [Related]
40. A new antitumor antibiotic, BE-19412A, produced by a streptomycete.
Tsukamoto M; Nakajima S; Arakawa H; Sugiura Y; Suzuki H; Hirayama M; Kamiya S; Teshima Y; Kondo H; Kojiri K; Suda H
J Antibiot (Tokyo); 1998 Oct; 51(10):908-14. PubMed ID: 9917003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
